Md Yuzaiful Md Yusof on infection and drug survival from the use of biological therapies in RA-associated bronchiectasis episode artwork

EPISODE · Oct 6, 2020 · 13 MIN

Md Yuzaiful Md Yusof on infection and drug survival from the use of biological therapies in RA-associated bronchiectasis

from The Rheumatology Podcast · host Oxford University Press

Dr Chris Wincup asks Dr Md Yuzaiful Md Yusof (Leeds, UK) about his recent paper, which examines the effect of rituximab and TNF inhibitors on lung infection and survival in RA-associated bronchiectasis. They discuss the study’s aims, design and main findings, as well as key messages for clinicians.

Episode metadata supplied by the publisher feed · Published Oct 6, 2020

Embed this episode

Ready to play

Md Yuzaiful Md Yusof on infection and drug survival from the use of biological therapies in RA-associated bronchiectasis

0:00 13:50

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Rheumatology Podcast?

This episode is 13 minutes long.

When was this The Rheumatology Podcast episode published?

This episode was published on October 6, 2020.

Can I download this The Rheumatology Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!